Literature DB >> 11090168

Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory.

J P Christensen1, P C Doherty, K C Branum, J M Riberdy.   

Abstract

The recall of CD8(+) T-cell memory established by infecting H-2(b) mice with an H1N1 influenza A virus provided a measure of protection against an extremely virulent H7N7 virus. The numbers of CD8(+) effector and memory T cells specific for the shared, immunodominant D(b)NP(366) epitope were greatly increased subsequent to the H7N7 challenge, and though lung titers remained as high as those in naive controls for 5 days or more, the virus was cleared more rapidly. Expanding the CD8(+) memory T-cell pool (<0.5 to >10%) by sequential priming with two different influenza A viruses (H3N2-->H1N1) gave much better protection. Though the H7N7 virus initially grew to equivalent titers in the lungs of naive and double-primed mice, the replicative phase was substantially controlled within 3 days. This tertiary H7N7 challenge caused little increase in the magnitude of the CD8(+) D(b)NP(366)(+) T-cell pool, and only a portion of the memory population in the lymphoid tissue could be shown to proliferate. The great majority of the CD8(+) D(b)NP(366)(+) set that localized to the infected respiratory tract had, however, cycled at least once, though recent cell division was shown not to be a prerequisite for T-cell extravasation. The selective induction of CD8(+) T-cell memory can thus greatly limit the damage caused by a virulent influenza A virus, with the extent of protection being directly related to the number of available responders. Furthermore, a large pool of CD8(+) memory T cells may be only partially utilized to deal with a potentially lethal influenza infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090168      PMCID: PMC112451          DOI: 10.1128/jvi.74.24.11690-11696.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  In vivo proliferation of naïve and memory influenza-specific CD8(+) T cells.

Authors:  K J Flynn; J M Riberdy; J P Christensen; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 2.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.

Authors:  E C Claas; A D Osterhaus; R van Beek; J C De Jong; G F Rimmelzwaan; D A Senne; S Krauss; K F Shortridge; R G Webster
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

4.  Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

Authors:  S L Rowland-Jones; T Dong; L Dorrell; G Ogg; P Hansasuta; P Krausa; J Kimani; S Sabally; K Ariyoshi; J Oyugi; K S MacDonald; J Bwayo; H Whittle; F A Plummer; A J McMichael
Journal:  Immunol Lett       Date:  1999-03       Impact factor: 3.685

5.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

6.  Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.

Authors:  A Seth; I Ourmanov; M J Kuroda; J E Schmitz; M W Carroll; L S Wyatt; B Moss; M A Forman; V M Hirsch; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Protection against a lethal avian influenza A virus in a mammalian system.

Authors:  J M Riberdy; K J Flynn; J Stech; R G Webster; J D Altman; P C Doherty
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.

Authors:  W B Dyer; G S Ogg; M A Demoitie; X Jin; A F Geczy; S L Rowland-Jones; A J McMichael; D F Nixon; J S Sullivan
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Virus-specific CD8+ T cells in primary and secondary influenza pneumonia.

Authors:  K J Flynn; G T Belz; J D Altman; R Ahmed; D L Woodland; P C Doherty
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

10.  Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.

Authors:  K Mozdzanowska; K Maiese; M Furchner; W Gerhard
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

View more
  58 in total

1.  Measuring the diaspora for virus-specific CD8+ T cells.

Authors:  D R Marshall; S J Turner; G T Belz; S Wingo; S Andreansky; M Y Sangster; J M Riberdy; T Liu; M Tan; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells.

Authors:  Megan K L MacLeod; Amy S McKee; Alexandria David; Jieru Wang; Robert Mason; John W Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Quantitative analysis of long-term virus-specific CD8+-T-cell memory in mice challenged with unrelated pathogens.

Authors:  Haiyan Liu; Samita Andreansky; Gabriela Diaz; Stephen J Turner; Dominik Wodarz; Peter C Doherty
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.

Authors:  Yuk-Fai Lau; Celia Santos; Fernando J Torres-Vélez; Kanta Subbarao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

5.  Toward a broadly protective influenza vaccine.

Authors:  Peter C Doherty; Anne Kelso
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans.

Authors:  Olga Pleguezuelos; Stuart Robinson; Ana Fernández; Gregory A Stoloff; Alex Mann; Anthony Gilbert; Ganesh Balaratnam; Tom Wilkinson; Rob Lambkin-Williams; John Oxford; Wilson Caparrós-Wanderley
Journal:  Clin Vaccine Immunol       Date:  2015-05-20

7.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 8.  Mammalian models for the study of H7 virus pathogenesis and transmission.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans.

Authors:  Douglas V Dolfi; Kathleen D Mansfield; Antonio M Polley; Susan A Doyle; Gordon J Freeman; Hanspeter Pircher; Kenneth E Schmader; E John Wherry
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

10.  DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

Authors:  Suzanne L Epstein; Terrence M Tumpey; Julia A Misplon; Chia-Yun Lo; Lynn A Cooper; Kanta Subbarao; Mary Renshaw; Suryaprakash Sambhara; Jacqueline M Katz
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.